Infinity Medical (IMED) LP

www.infinitymedical.co.il

Formerly IIM, Medination

Venture Capital Fund

Final Closing

Tech Verticals Preferences

Artificial Intelligence, Big Data, Biotechnology, Digital Health, Healthtech, IoT, MedTech, Wearables

General Data

Management Company:	Infinity Medical (IMED) Ltd.
Vintage Year	2020
Current Active Portfolio Companies:	5
Reg. Number:	abCDe

DESCRIPTION

Infinity Medical (IMED) is a public Limited R&D Partnership (TASE:IMED.L), established to harness innovative startups and bring digital health solutions to the world. Its focus is on advanced digital health technologies, with portfolio companies on the cutting edge of health innovation, in transition from development to global sales. Infinity medical team consists of experts in the fields of medicine, technology, business and finance.

Infinity Medical will usually invest in a firm that has an existing product, regulatory approvals, and a clear exit path at the start of the sales, growth, and commercialization stages.

The Infinity Group has spent many years in the Chinese market, leading to an extensive contact network and a high level of business expertise. This constitute an ideal platform for the development of young companies and a very significant power multiplier.

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	132 Menachem Begin Road, Triangle Tower, 42nd Floor
City	Tel Aviv
Country	Israel
Zip	6701101

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Tel Aviv, Israel

Address	30 Habarzel Road, 7th Floor
City	Tel Aviv
Country	Israel
Zip	6971042

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Itay Gal-Or	CEO

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Dec. 24, 2020	IPO	TASE	abCDe	abCDe	Raised NIS 40.35m from institutional and private investors, including the partnership's General Partner.

Investment Data

Managed Capital	abCDe
Capital Remarks	Infinity Medical is a Limited R&D Partnership. It raised NIS 40.35m through an IPO at TASE.

Preferences

Maximum investments	$2m
Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D

SECTOR SEGMENTATION (By Number Of Companies)

Digital Health

60%

Medical Devices

40%

	PORTFOLIO COMPANIES

Current Portfolio Companies (5)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Biobeat

Dig. Health

Second Round

27/12/2020

$1.9m

Invested NIS 6m.

Cytoreason

Dig. Health

Fourth Round - Extended

30/12/2021

$1m

Nerivio

Theranica is a developer of electroceuticals, intended to address prevalent neurological pain diseases. The company's product offers an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable use-and-dispose, providing temporary or long-term pain relief, enabling patients to treat acute migraines in an affordable manner.

Third Round	29/08/2022	N/A	$45m
Second Round - Extended	31/08/2021	$1m	$1m

Polarisqb

Dig. Health

First Round

10/08/2021

$0.3m

$2.1m

SpinCare

Second Round

31/01/2022

$0.75m

$3.5m

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	26/07/2025	abCDe	The total value of the acquisition could grow to $250m, contingent on Cynerio achieving specific milestones. As part of the acquisition deal, RDC received 0.6% of Axonius' shares.
abC Defghij	Acquired	12/05/2025	abCDe

Last Updated:	abCDe
IVC Number:	abCDe